GLP-1 Program FAQ

MDDPC manages a clinically guided Weight Management Program designed to help patients achieve sustainable weight loss through medically supervised care, advanced GLP-1/GIP therapies, and ongoing physician oversight.
The program combines convenience, clinical safety, and predictable pricing and managed directly through CareValet's Platform.

MDDPC offers two advanced, evidence-based medications: semaglutide and tirzepatide.

• Semaglutide is a GLP-1 (Glucagon-Like Peptide-1) receptor agonist that helps reduce appetite and improve glucose control.
• Tirzepatide is a dual GIP and GLP-1 receptor agonist (“twincretin”) that engages two metabolic pathways to enhance weight loss and improve insulin sensitivity.
  Both medications are prescribed based on clinical review and are included at one flat monthly price, regardless of dosage level or titration stage.

MDDPC manages a structured eligibility review process beginning with an online process. This form collects information directly from the member.  A provider reviews each submission to determine medical appropriateness.
In general, adults with a BMI of 27 or greater (or 25+ with related conditions such as hypertension or insulin resistance) may qualify, provided there are no contraindications such as pregnancy, severe gastrointestinal disease, or certain thyroid conditions.

MDDPC physicians determine which medication is best suited for each member based on the assessment submitted.
Dosing starts low and increases gradually to optimize results and minimize side effects.
Dosages may be reviewed every 90 days as part of a quarterly review or sooner if requested by the patient.

Each MDDPC membership includes up to six virtual physician visits per year, covering quarterly evaluations and additional consultations for progress or medication adjustments.
All visits occur through MDDPC’s platform. Patients may contact their provider through the portal to request a check-in or dosage review.

The program operates entirely on a direct membership model at $245 per month*, which includes:

• Provider oversight and six annual visits
• All medication doses (semaglutide or tirzepatide)
• Medication shipping and support
• Note: Some group healthplans may cover all or part of the payment

There are no hidden fees or insurance requirements just transparent pricing and predictable care.

* Minimum 3 Month Subscription

MDDPC manages the patient journey from start to finish:

1. Complete Assessment – Submit your online evaluation at CareValet MDDPC Assessment Link
2. Provider Review – A clinician reviews eligibility and prescribes medication.
3. Medication Fulfillment – Your medication is compounded and shipped monthly from MDDPC’s pharmacy partner.
4. Ongoing Care – Regular check-ins every 90 days and as needed for dose adjustments, progress tracking, and continued support.

Most members begin seeing results within 4–8 weeks, with continued improvements over time when adhering to physician guidance and lifestyle recommendations.

MDDPC delivers physician-supervised, pharmacy-integrated, and patient-centered weight management combining modern GLP